Achieve Announces Presentation of Investigator-Led RAUORA Trial Data Demonstrating Significantly Fewer Side Effects with Higher Quit Rates for Cytisinicline (cytisine) Compared to Chantix® (varenicline) in First Head-to-Head Comparative Study
SEATTLE and VANCOUVER, BC, Sept. 18, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation…
RealNetworks Strengthens SAFR’s Leadership Team with Appointment of Brad Donaldson as Vice President, Computer Vision
SEATTLE, Sept. 18, 2020 /PRNewswire/ -- RealNetworks, Inc. (Nasdaq: RNWK) today announced the appointment of Brad Donaldson as Vice President, Computer Vision to lead the strategic development and market expansion of…
The Medical Device Epidemiology Network (MDEpiNet) and Medstreaming/M2S Establish Collaboration to Advance Real-World Evaluation of Medical Devices
REDMOND, Wash., Sept. 18, 2020 /PRNewswire/ -- The Medical Device Epidemiology Network (MDEpiNet) and Medstreaming/M2S have established a strategic collaboration to advance real-world evaluation of medical devices. This collaboration combines the…